is a welt.at.injecrion sote concernign for glp 1 GLP-1 Injection Site Reactions: What Are They, How to Avoid Them, and The GLP-1 Injection Site Map:

11 Perna et al reported that in obese elderly patients receiving 24 weeks of treatment with liraglutide, there was a significant reduction in fat mass, but no reduction in appendicular lean mass

*Manufacturer/Brand*: Associated with (Jan Aushadhi Project), a government initiative in India for affordable medicines

And thats when we had to press pause and rebuild, the right way

A long-acting release (LAR) preparation of exenatide (a synthetic form of exendin-4) has been developed for once weekly injection by incorporating it into a poly (D,L-lactic-co-glycolic acid) microsphere suspension with biodegradable microparticles [17]

Note: Product availability and specifications subject to change